Dr.Yoshino, chairman of 22CEMIT, has started the world's largest investigator-initiated trial,
CIRCULATE-Japan.
For patients recieving colorectal cancer surgery, applying the techniques which can specifies possibility of cancer recurrence, we will develop better treatment methods after surgery.
Click here for details:
https://www.ncc.go.jp/jp/information/pr_release/2020/0610/index.html
Related information
Dr.Yoshino, a chairman of the 22CEMIT organization, has initiated the world's largest-scale investigator-initiated clinical trials.
Dr.Yoshino, a chairman of the 22CEMIT organization, has initiated the world's largest-scale investigator-initiated clinical trials, named as the CIRCULATE-Japan.
For colorectal cancer patients who will receive a curative surgery, using the cutting-edge technology which is able to stratify the recurrence risk, we will establish the optimal treatment strategy after surgery.
English 
Japanese